ABVX

ABIVAX Société Anonyme

Price Chart

No historical data available

Latest Quote

$112.78

-1.52 (-1.33%)

Current Price

Previous Close	$114.30
Open	$114.34
Day High	$115.17
Day Low	$111.72
Volume	533,394

Fetched: 2026-08-28T18:40:06

Stock Information

Note: Financial values converted from EUR to USD

Shares Outstanding	87.25M
Total Debt	$39.64M
Cash Equivalents	$569.59M
Revenue	$5.70M
Net Income	$-384.94M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$9.89B
EPS (TTM)	$-5.38
Exchange	NGM

🌐 Visit Website

Recent Price History

No history data available. Data will be fetched automatically.

About ABIVAX Société Anonyme

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.

📰 Latest News

No news articles available at the moment. Check back later for updates on ABVX.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue
Total Revenue	$0	$0	$0	$0
Operating Revenue	$0	$0	$0	$0
Reconciled Cost Of Revenue	-	-	-	$59,005,021
Cost Of Revenue	-	-	-	$59,282,961
Expenses
Interest Expense	$33,261,707	$14,517,108	$16,146,210	$8,104,636
Total Expenses	$287,347,888	$202,013,310	$148,752,771	$59,797,967
Other Income Expense	$-37,032,581	$3,122,737	$-12,673,128	$-4,981,899
Net Non Operating Interest Income Expense	$-61,293,938	$-6,926,311	$-11,105,921	$-6,155,553
Total Other Finance Cost	$34,750,671	$2,868,154	$-1,801,939	$-1,949,083
Interest Expense Non Operating	$33,261,707	$14,517,108	$16,146,210	$8,104,636
Operating Expense	$287,347,888	$202,013,310	$148,752,771	$59,797,967
Other Operating Expenses	$-5,336,915	$-14,536,961	$-5,396,473	$-5,352,096
Selling And Marketing Expense	$261,591	$1,088,404	$827,981	$0
General And Administrative Expense	$84,831,249	$44,339,600	$32,830,783	$8,750,438
Other Non Operating Income Expenses	-	$-1,596,403	$3,734,672	$1,688,660
Rent Expense Supplemental	-	-	-	$1,223,870
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Net Interest Income	$-61,293,938	$-6,926,311	$-11,105,921	$-6,155,553
Interest Income	$6,718,440	$10,458,951	$3,238,351	$0
Normalized Income	$-364,730,521	$-208,940,789	$-159,859,860	$-65,951,184
Net Income From Continuing And Discontinued Operation	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Total Operating Income As Reported	$-287,347,888	$-202,013,310	$-148,751,603	$-75,716,453
Net Income Common Stockholders	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Net Income	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Net Income Including Noncontrolling Interests	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Net Income Continuous Operations	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Pretax Income	$-385,675,575	$-205,818,051	$-172,532,988	$-70,933,083
Special Income Charges	$-4,482,074	$0	$-3,782,553	$-15,919,654
Interest Income Non Operating	$6,718,440	$10,458,951	$3,238,351	$0
Operating Income	$-287,347,888	$-202,013,310	$-148,752,771	$-59,797,967
Depreciation Amortization Depletion Income Statement	-	-	-	$82,915
Depreciation And Amortization In Income Statement	-	-	-	$82,915
Depreciation Income Statement	-	-	-	$82,915
Gross Profit	-	-	-	$-59,282,961
Per Share
Diluted EPS	$-5.64	$-3.25	$-4.01	$-3.71
Basic EPS	$-5.64	$-3.25	$-4.01	$-3.71
Other
Tax Effect Of Unusual Items	$-9,258,145	$0	$0	$0
Tax Rate For Calcs	$0	$0	$0	$0
Normalized EBITDA (Bullshit earnings)	$-314,129,389	$-193,139,084	$-142,888,004	$-57,280,158
Total Unusual Items	$-37,032,581	$3,122,737	$-12,673,128	$-4,981,899
Total Unusual Items Excluding Goodwill	$-37,032,581	$3,122,737	$-12,673,128	$-4,981,899
Reconciled Depreciation	$1,251,898	$1,284,596	$825,645	$566,390
EBITDA (Bullshit earnings)	$-351,161,970	$-190,016,346	$-155,561,133	$-62,262,057
EBIT	$-352,413,868	$-191,300,943	$-156,386,778	$-62,828,447
Diluted Average Shares	$81,195,041	$73,978,554	$50,293,135	$22,296,440
Basic Average Shares	$81,195,041	$73,978,554	$50,293,135	$22,296,440
Diluted NI Availto Com Stockholders	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Tax Provision	$6,829,382	$0	$0	$0
Other Special Charges	$4,482,074	-	$3,782,553	$16,197,594
Gain On Sale Of Security	$-32,550,507	$3,122,737	$-8,890,576	$10,937,755
Research And Development	$207,591,962	$171,122,268	$120,490,480	$56,399,625
Selling General And Administration	$85,092,840	$45,428,004	$33,658,764	$8,750,438
Other Gand A	$19,242,088	$18,931,449	$15,529,604	$7,111,993
Salaries And Wages	$65,589,162	$25,408,151	$17,301,179	$1,638,444
Impairment Of Capital Assets	-	$0	$0	$15,919,654
Restructuring And Mergern Acquisition	-	$1,596,403	$-3,734,672	$-1,688,660
Otherunder Preferred Stock Dividend	-	-	$0	$0
Other Taxes	-	-	-	$51,384
Rent And Landing Fees	-	-	-	$1,223,870

Fetched: 2026-08-23

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Assets
Net Tangible Assets	$502,371,825	$18,170,034	$199,681,183	$-20,830,316
Total Assets	$682,402,185	$239,668,337	$381,947,910	$88,221,416
Total Non Current Assets	$38,651,173	$40,357,351	$47,985,518	$45,968,702
Other Non Current Assets	$-1,168	$2,336	$2,709,331	$1,209,856
Non Current Prepaid Assets	$6,987,037	$7,871,073	$17,594,301	$13,673,946
Investmentin Financial Assets	$0	$147,145	$144,809	$0
Goodwill And Other Intangible Assets	$29,223,403	$29,224,570	$29,222,235	$29,225,738
Other Intangible Assets	$7,713,418	$7,714,586	$7,712,250	$7,715,754
Current Assets	$643,751,012	$199,312,154	$333,962,391	$42,252,715
Prepaid Assets	$12,105,570	$12,597,220	$6,869,088	$1,068,551
Receivables	$12,256,218	$18,291,486	$22,304,099	$9,711,550
Other Receivables	$500,993	-	$70,069	$296,625
Taxes Receivable	$11,755,226	$18,235,431	$22,234,030	$9,414,925
Notes Receivable	$0	$56,055	$70,069	$296,625
Cash Cash Equivalents And Short Term Investments	$619,389,223	$168,423,447	$304,790,372	$31,472,614
Cash And Cash Equivalents	$603,392,493	$168,423,447	$294,221,647	$31,472,614
Cash Equivalents	$558,847,358	$101,909,376	$21,143,291	$31,465,607
Cash Financial	$44,545,135	$66,514,071	$273,078,356	$7,007
Non Current Deferred Assets	-	-	$2,709,331	$1,211,024
Other Current Assets	-	-	$-1,168	-
Current Deferred Assets	-	-	$6,710,265	$1,068,551
Non Current Note Receivables	-	-	-	$1,445,755
Inventory	-	-	-	-
Accounts Receivable	-	-	-	-
Debt
Total Debt	$2,167,465	$113,699,636	$67,784,654	$45,732,803
Long Term Debt And Capital Lease Obligation	$646,970	$62,585,541	$31,278,757	$10,658,648
Current Debt And Capital Lease Obligation	$1,520,495	$51,114,095	$36,505,897	$35,074,156
Long Term Debt	-	$60,914,398	$31,091,907	$9,678,851
Current Debt	-	$50,025,691	$36,063,295	$34,437,697
Other Current Borrowings	-	$50,025,691	$36,063,295	$34,437,697
Net Debt	-	-	-	$12,643,933
Liabilities
Total Liabilities Net Minority Interest	$150,806,958	$192,273,733	$153,044,491	$79,825,994
Total Non Current Liabilities Net Minority Interest	$77,210,089	$83,860,795	$50,142,473	$19,726,731
Other Non Current Liabilities	$35,311,222	$15,208,455	$18,094,126	$7,648,020
Derivative Product Liabilities	$0	$4,227,490	$0	$660,983
Non Current Deferred Liabilities	$6,829,382	$0	$0	-
Non Current Deferred Taxes Liabilities	$6,829,382	$0	$0	-
Current Liabilities	$73,596,869	$108,412,938	$102,902,019	$60,099,263
Current Deferred Liabilities	$0	$0	$60,726	$155,319
Payables And Accrued Expenses	$52,188,485	$56,677,565	$62,237,533	$20,757,912
Payables	$52,188,485	$56,677,565	$62,237,533	$20,757,912
Total Tax Payable	$8,334,696	$5,499,241	$7,092,140	$2,685,974
Accounts Payable	$43,853,789	$51,178,325	$55,145,392	$18,071,937
Other Current Liabilities	-	-	$4,097,863	$4,111,877
Other Payable	-	-	$4,313,909	$1,574,215
Interest Payable	-	-	-	$764,919
Equity
Common Stock Equity	$531,595,227	$47,394,604	$228,903,418	$8,395,422
Total Equity Gross Minority Interest	$531,595,227	$47,394,604	$228,903,418	$8,395,422
Stockholders Equity	$531,595,227	$47,394,604	$228,903,418	$8,395,422
Gains Losses Not Affecting Retained Earnings	$2,696,485	$-87,586	$130,795	$0
Retained Earnings	$-862,410,357	$-512,529,479	$-330,432,086	$-167,593,131
Other Equity Interest	-	-	-	$7,963,330
Other
Ordinary Shares Number	$91,716,000	$73,978,554	$73,475,976	$26,043,658
Share Issued	$91,716,000	$73,978,554	$73,489,218	$26,043,658
Tangible Book Value	$502,371,825	$18,170,034	$199,681,183	$-20,830,316
Invested Capital	$531,595,227	$158,334,693	$296,058,620	$52,511,969
Working Capital	$570,154,143	$90,899,216	$231,060,372	$-17,846,549
Capital Lease Obligations	$2,167,465	$2,759,547	$629,452	$1,616,256
Total Capitalization	$531,595,227	$108,309,002	$259,995,325	$18,074,273
Foreign Currency Translation Adjustments	$2,696,485	$-87,586	$130,795	$0
Additional Paid In Capital	$1,390,392,364	$559,272,443	$558,470,154	$175,728,130
Capital Stock	$916,735	$739,227	$734,556	$260,423
Common Stock	$916,735	$739,227	$734,556	$260,423
Employee Benefits	$732,220	$882,868	$734,556	$712,367
Non Current Pension And Other Postretirement Benefit Plans	$732,220	$882,868	$734,556	$712,367
Long Term Capital Lease Obligation	$646,970	$1,671,143	$186,850	$979,797
Long Term Provisions	$33,690,295	$956,440	$35,034	$46,713
Current Deferred Revenue	$0	$0	$60,726	$155,319
Current Capital Lease Obligation	$1,520,495	$1,088,404	$442,602	$636,459
Current Provisions	$19,887,889	$621,278	-	-
Investments And Advances	$0	$147,145	$144,809	$0
Goodwill	$21,509,984	$21,509,984	$21,509,984	$21,509,984
Net PPE	$2,441,901	$3,112,227	$1,024,174	$1,859,161
Accumulated Depreciation	$-2,549,340	$-1,592,900	$-1,738,877	$-943,595
Gross PPE	$4,991,241	$4,705,127	$2,763,050	$2,802,756
Other Properties	$540,698	$599,089	$599,089	$509,167
Machinery Furniture Equipment	$708,864	$815,135	$592,082	$404,064
Buildings And Improvements	$3,741,679	$3,290,903	$1,571,879	$1,889,525
Properties	$0	$0	$0	$0
Other Short Term Investments	$15,996,730	$0	$10,568,726	$0
Available For Sale Securities	-	$147,145	$144,809	$89,922
Treasury Shares Number	-	-	$13,242	$14,014
Pensionand Other Post Retirement Benefit Plans Current	-	-	-	$1,348,826
Current Accrued Expenses	-	-	-	$764,919
Construction In Progress	-	-	-	$78,244
Work In Process	-	-	-	-

Fetched: 2026-08-23

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Free Cash Flow
Free Cash Flow	$-188,334,693	$-180,678,498	$-113,739,342	$-63,364,474
Operating Activities
Operating Cash Flow	$-188,168,863	$-179,927,593	$-113,429,871	$-62,987,270
Cash Flow From Continuing Operating Activities	$-188,170,031	$-179,928,760	$-113,429,871	$-62,983,766
Operating Gains Losses	$72,714,001	$1,721,359	$-1,264,744	$-12,591,381
Investing Activities
Capital Expenditure	$-165,830	$-750,905	$-309,471	$-377,204
Investing Cash Flow	$-9,567,908	$18,407,100	$-9,453,462	$-14,044,143
Cash Flow From Continuing Investing Activities	$-9,567,908	$18,408,268	$-9,453,462	$-14,044,143
Net Other Investing Changes	$-15,860,096	$9,607,614	$-11,946,747	$-10,287,282
Financing Activities
Issuance Of Capital Stock	$756,888,929	$506,832	$412,690,639	$54,156,253
Financing Cash Flow	$639,153,324	$32,940,558	$391,556,691	$37,616,489
Cash Flow From Continuing Financing Activities	$639,153,324	$32,940,558	$391,555,524	$37,617,657
Net Other Financing Charges	$-47,429,638	$-2,355,483	$-32,765,385	$-510,335
Cash Dividends Paid	$0	$0	$0	$0
Net Common Stock Issuance	$756,888,929	$506,832	$412,690,639	$54,156,253
Common Stock Issuance	$756,888,929	$506,832	$412,690,639	$54,156,253
Other
Repayment Of Debt	$-69,523,530	$-12,213,009	$-47,415,625	$-11,340,651
Issuance Of Debt	$0	$55,989,722	$65,211,957	$0
End Cash Position	$603,392,493	$168,423,447	$294,221,647	$31,472,614
Beginning Cash Position	$168,423,447	$294,221,647	$31,472,614	$70,887,538
Effect Of Exchange Rate Changes	$-11,971,272	$2,781,735	$-5,923,158	$0
Changes In Cash	$446,940,318	$-128,579,935	$268,672,190	$-39,414,924
Other Cash Adjustment Inside Changein Cash	$5,523,765	$0	$0	-
Interest Paid Cff	$-7,579,119	$-8,987,504	$-6,164,895	$-4,688,777
Proceeds From Stock Option Exercised	$6,796,683	$0	$0	$3,503
Net Issuance Payments Of Debt	$-69,523,530	$43,776,713	$17,796,333	$-11,340,651
Net Long Term Debt Issuance	$-69,523,530	$43,776,713	$17,796,333	$-11,340,651
Long Term Debt Payments	$-69,523,530	$-12,213,009	$-47,415,625	$-11,340,651
Long Term Debt Issuance	$0	$55,989,722	$65,211,957	$0
Interest Received Cfi	$6,458,017	$9,550,391	$2,802,756	$22,188
Net Intangibles Purchase And Sale	$0	$-3,503	$0	$-40,874
Purchase Of Intangibles	$0	$-3,503	$0	$-40,874
Net PPE Purchase And Sale	$-165,830	$-747,402	$-309,471	$-336,331
Purchase Of PPE	$-165,830	$-747,402	$-309,471	$-336,331
Change In Working Capital	$4,264,860	$1,661,801	$24,834,754	$-2,337,966
Change In Other Working Capital	$829,149	$2,058,858	$-94,593	$-30,363
Change In Payables And Accrued Expense	$-4,788,042	$-5,758,496	$41,548,522	$-2,671,961
Change In Payable	$-4,788,042	$-5,758,496	$41,548,522	$-2,671,961
Change In Account Payable	$-7,252,131	$-4,021,955	$37,086,301	$-2,788,742
Change In Tax Payable	$2,464,090	$-1,736,541	$4,462,221	$116,782
Change In Income Tax Payable	$2,464,090	$-1,736,541	$4,462,221	$116,782
Change In Receivables	$8,223,753	$5,361,439	$-16,619,175	$364,358
Other Non Cash Items	$25,730,468	$-2,395,189	$25,155,903	$7,748,453
Stock Based Compensation	$41,337,148	$23,617,891	$9,551,559	$-1,359,337
Provisionand Write Offof Assets	$52,208,337	$0	$0	-
Deferred Tax	$6,829,382	$0	$0	-
Deferred Income Tax	$6,829,382	$0	$0	-
Depreciation Amortization Depletion	$1,251,898	$1,284,596	$825,645	$566,390
Depreciation And Amortization	$1,251,898	$1,284,596	$825,645	$566,390
Pension And Employee Benefit Expense	$-75,908	$86,418	$127,292	$166,998
Gain Loss On Investment Securities	$72,789,909	$1,634,941	$-1,392,035	$-12,758,379
Net Income From Continuing Operations	$-392,504,957	$-205,818,051	$-172,532,988	$-70,933,083
Net Business Purchase And Sale	-	$0	$0	$-3,401,845
Purchase Of Business	-	$0	$0	$-3,401,845
Asset Impairment Charge	-	$0	$0	$15,919,654
Other Cash Adjustment Outside Changein Cash	-	-	$-1,168	$-3,503
Net Investment Purchase And Sale	-	-	$-10,054,887	$-548,873
Sale Of Investment	-	-	$865,351	$254,584
Purchase Of Investment	-	-	$-10,920,238	$-548,873
Change In Other Current Assets	-	-	$4,367,628	$-37,370
Amortization Cash Flow	-	-	$0	$360,855
Amortization Of Intangibles	-	-	$0	$360,855
Depreciation	-	-	$826,813	-
Net Foreign Currency Exchange Gain Loss	-	-	$6,508,233	$0
Sale Of PPE	-	-	-	-
Taxes Refund Paid	-	-	-	-
Interest Received Cfo	-	-	-	-
Interest Paid Cfo	-	-	-	-
Change In Other Current Liabilities	-	-	-	-
Changes In Account Receivables	-	-	-	-

Fetched: 2026-08-23